7 nonpharma approaches to treat mild anxiety disorders

Slideshow

For children who have milder forms of anxiety disorders, the clinician can use nonpharmaceutical treatment options to treat. Here are 7 approaches that can be used to mitigate the effects of a mild anxiety disorder.

Recent Videos
Diet, mental health, and pediatric nutrition, with Colleen Sloan, PA-C, RDN
Victor Carrion, MD
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Jennifer Soung, MD reacts to FDA approval of roflumilast foam 0.3%
Supporting mental health in pediatric primary care with Victor Carrion, MD
Discussing social media and potential nutrition impacts with Colleen Sloan, PA-C, RDN
Jenna Marcovitz, MA explains how music therapy helps in pediatric care
Related Content
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD

How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD

John Browning, MD
June 11th 2025
Article

John Browning, MD, highlights the importance of fragrance-free, steroid-free creams in managing atopic dermatitis safely and effectively in children.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Study: Childhood adversity linked to elevated risk of endometriosis | Image Credit: © New Africa - stock.adobe.com.

Study: Childhood adversity linked to elevated risk of endometriosis

Morgan Ebert, Managing Editor
June 11th 2025
Article

Childhood adversity may raise endometriosis risk, with exposure to violence linked to a twofold increase, a Swedish study of 1.3M women finds.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital

Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention

Octavio Ramilo, MD
June 10th 2025
Article

Ramilo, a clesrovimab clinical trial investigator, breaks down the recent FDA approval for the newest monoclonal antibody to protect against RSV disease in infants.

FDA approves clesrovimab to protect infants during first RSV season | Image Credit: Contemporary Pediatrics

FDA approves clesrovimab to protect infants during first RSV season

Joshua Fitch, Senior Editor
June 9th 2025
Article

The BLA for clesrovimab was based on results demonstrated in the phase 2b/3 CLEVER trial among healthy pre-term and full-term infants.

© 2025 MJH Life Sciences

All rights reserved.